Showing results (1741-1750 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|July 11, 2022
A Case of Pneumonia Masking Pleural MalignancyQian Xu, Juanjuan Tian, Lin Huang, et al.Oncotargets and Therapy|May 23, 2019
IL-37 promotes cell apoptosis in cervical cancer involving Bim upregulationPing Ouyang, Weifang An, Renhuai Chen, et al.Oncotargets and Therapy|May 23, 2019
MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancerYan Wang, Meng Zhao, Huishan Zhao, et al.Oncotargets and Therapy|May 23, 2019
SIRT6 promotes the Warburg effect of papillary thyroid cancer cell BCPAP through reactive oxygen speciesWeiping Yu, Zhou Yang, Renhong Huang, et al.Oncotargets and Therapy|May 23, 2019
CD5-negative chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with gastrointestinal mantle cell lymphoma: an unusual case reportDangui Chen, Yang Zhan, Jun Peng, et al.Oncotargets and Therapy|May 23, 2019
Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosisJun He, Zhulin Yang, Zhengchun Wu, et al.Oncotargets and Therapy|May 23, 2019
Large-cell neuroendocrine carcinoma of nasal cavity and paranasal sinuses after successful curative therapy: a case report and literature reviewQin Zhao, Jinlong Wei, Chengbin Zhang, et al.Oncotargets and Therapy|May 23, 2019
MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastomaWeijie Chen, Baochen Huang, Enqin Wang, et al.Oncotargets and Therapy|May 23, 2019
Numb inhibits cell proliferation, invasion, and epithelial-mesenchymal transition through PAK1/β-catenin signaling pathway in ovarian cancerJiabin Liang, Bingbing Han, Yunhe Zhang, et al.Oncotargets and Therapy|October 11, 2021
Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic ReviewHassaan Imtiaz, Maimoona Khan, Hamid Ehsan, et al.Pageof 672